Literature DB >> 24235191

Treatment and prevention of ophthalmia neonatorum.

Adela Matejcek1, Ran D Goldman.   

Abstract

QUESTION: In my office I occasionally see neonates with conjunctivitis. What are the current recommendations for ocular prophylaxis at birth? Do topical antibiotics alone provide adequate treatment of neonatal conjunctivitis? When is systemic therapy indicated? ANSWER: All infants should receive ocular prophylaxis at birth to prevent gonococcal ophthalmia. Neonates presenting with signs of conjunctivitis should have a conjunctival swab sent for Gram stain and culture. If Gram-negative diplococci are present on the Gram stain results, the infants and their parents should be treated immediately for presumed gonorrhea. Infants with chlamydial infection should be treated with oral antibiotics. Most of all other forms of bacterial conjunctivitis can be treated with topical antibiotics, with the exception of Pseudomonas infection. Infants should be followed during their treatment and upon completion of therapy to ensure resolution of symptoms. For cases in which sexually transmitted bacteria are implicated, the mothers and their sexual partners should be treated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24235191      PMCID: PMC3828094     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  16 in total

Review 1.  Diagnosis and management of pediatric conjunctivitis.

Authors:  Doreen L Teoh; Sally Reynolds
Journal:  Pediatr Emerg Care       Date:  2003-02       Impact factor: 1.454

2.  Treatment of neonatal chlamydial conjunctivitis with azithromycin.

Authors:  M R Hammerschlag; M Gelling; P M Roblin; A Kutlin; J E Jule
Journal:  Pediatr Infect Dis J       Date:  1998-11       Impact factor: 2.129

Review 3.  Chlamydia trachomatis infections in neonates and young children.

Authors:  Toni Darville
Journal:  Semin Pediatr Infect Dis       Date:  2005-10

4.  Incidence of Chlamydia trachomatis and other potential pathogens in neonatal conjunctivitis.

Authors:  S Di Bartolomeo; D H Mirta; M Janer; M R Rodríguez Fermepin; D Sauka; F Magariños; R A de Torres
Journal:  Int J Infect Dis       Date:  2001       Impact factor: 3.623

5.  Conjunctivitis: systematic approach to diagnosis and therapy.

Authors:  Onsiri Thanathanee; Terrence P O'Brien
Journal:  Curr Infect Dis Rep       Date:  2011-04       Impact factor: 3.725

Review 6.  Ophthalmia neonatorum: what kind of prophylaxis?

Authors:  Antonio Alberto Zuppa; Vito D'Andrea; Piero Catenazzi; Antonio Scorrano; Costantino Romagnoli
Journal:  J Matern Fetal Neonatal Med       Date:  2011-06

Review 7.  Pediatric ocular inflammation.

Authors:  Rudolph S Wagner; Marcella Aquino
Journal:  Immunol Allergy Clin North Am       Date:  2008-02       Impact factor: 3.479

8.  Recommendations for the prevention of neonatal ophthalmia.

Authors: 
Journal:  Paediatr Child Health       Date:  2002-09       Impact factor: 2.253

9.  Chlamydia trachomatis as a cause of neonatal conjunctivitis in Dutch infants.

Authors:  Ingrid G I J G Rours; Margaret R Hammerschlag; Alewijn Ott; Tjeerd J T H N De Faber; Henri A Verbrugh; Ronald de Groot; Roel P Verkooyen
Journal:  Pediatrics       Date:  2008-02       Impact factor: 7.124

10.  Epidemiology of ophthalmia neonatorum in Kenya.

Authors:  M Laga; F A Plummer; H Nzanze; W Namaara; R C Brunham; J O Ndinya-Achola; G Maitha; A R Ronald; L J D'Costa; V B Bhullar
Journal:  Lancet       Date:  1986-11-15       Impact factor: 79.321

View more
  10 in total

Review 1.  Management of Extraocular Infections.

Authors:  Srinivasan Muthiah; Naveen Radhakrishnan
Journal:  Indian J Pediatr       Date:  2017-07-14       Impact factor: 1.967

Review 2.  Eye pathologies in neonates.

Authors:  Nyaish Mansoor; Tihami Mansoor; Mansoor Ahmed
Journal:  Int J Ophthalmol       Date:  2016-12-18       Impact factor: 1.779

3.  Neonatal Prophylaxis: Prevention of Vitamin K Deficiency Haemorrhage and Neonatal Ophthalmia.

Authors:  Anita Jug Došler; Petra Petročnik; Ana Polona Mivšek; Teja Zakšek; Metka Skubic
Journal:  Zdr Varst       Date:  2015-06-09

4.  The eyes have it: An unusual case of Escherichia coli ophthalmia neonatorum or a shifting landscape?

Authors:  Walid Mounir Maalouli; Michael Barclay Pitt
Journal:  SAGE Open Med Case Rep       Date:  2017-12-11

5.  Fatty Acid Based Microemulsions to Combat Ophthalmia Neonatorum Caused by Neisseria gonorrhoeae and Staphylococcus aureus.

Authors:  Ummara Butt; Amr ElShaer; Lori A S Snyder; Ali A Al-Kinani; Adam Le Gresley; Raid G Alany
Journal:  Nanomaterials (Basel)       Date:  2018-01-19       Impact factor: 5.076

6.  Does azithromycin given to women in labour decrease ocular bacterial infection in neonates? A double-blind, randomized trial.

Authors:  Sarah E Burr; Bully Camara; Claire Oluwalana; Ebrima Bojang; Christian Bottomley; Abdoulie Bojang; Robin L Bailey; Umberto D'Alessandro; Anna Roca
Journal:  BMC Infect Dis       Date:  2017-12-28       Impact factor: 3.090

7.  Besifloxacin Ophthalmic Suspension 0.6% Compared with Gatifloxacin Ophthalmic Solution 0.3% for the Treatment of Bacterial Conjunctivitis in Neonates.

Authors:  Christine M Sanfilippo; Catherine M Allaire; Heleen H DeCory
Journal:  Drugs R D       Date:  2017-03

8.  A Survey of Current Prophylactic Treatment for Ophthalmia Neonatorum in Croatia and a Review of International Preventive Practices.

Authors:  Snježana Kaštelan; Sonja Anić Jurica; Slavko Orešković; Tomislav Župić; Mislav Herman; Antonela Gverović Antunica; Irena Marković; Ivana Bakija
Journal:  Med Sci Monit       Date:  2018-11-10

9.  The Growing Threat of Gonococcal Blindness.

Authors:  Victoria Dolange; Colin P Churchward; Myron Christodoulides; Lori A S Snyder
Journal:  Antibiotics (Basel)       Date:  2018-07-12

10.  Antimicrobial use in an Indonesian community cohort 0-18 months of age.

Authors:  Jarir At Thobari; Cahya Dewi Satria; Yohanes Ridora; Emma Watts; Amanda Handley; Samad Samad; Novilia S Bachtiar; Julie E Bines; Yati Soenarto; Jim P Buttery
Journal:  PLoS One       Date:  2019-08-05       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.